Skip to main content
Skip to footer
We're taking you to another TCS website now.


The World Drug Safety Congress (WDSC) Americas 2022, one of the largest congregation of pharmacovigilance (PV) professionals worldwide, is expected to bring together 1,000+ industry stakeholders in pharma to discuss the key challenges faced in pharmacovigilance (PV) and device safety. 

TCS is proud to be a ‘Diamond Sponsor’ for this reputed event and envisions to bridge the gaps enunciated by pharma organizations through a mix of technology, domain and contextual knowledge.

Drop by our booth (#1) to engage with our core PV leadership team, learn more about our deep PV transformation expertise and experience our purpose-built solution, TCS ADD™ Safety – An AI Platform for Pharmacovigilance. TCS is part of multiple speaking sessions wherein speakers from global top 10 pharma will join us and share insights in the areas of ‘AI and Machine Learning in PV’ and ‘Next Generation Tech & Data – New emerging tech in PV’. We eagerly look forward to some really interesting discussions and sharing proof-of-concept stories.

Join us to discover how we empower pharma organizations to take the next big leap with AI powered PV.






When AI meets PV

4th Oct | 12PM ET – 12:40PM ET

The Life Sciences industry is at an inflection point with charting out its future journey and envisioning a new approach to PV.  With the ever-increasing volume of reported adverse events, there is an immediate need to enable and accelerate digital transformation of the Safety Surveillance processes and experience the benefits of Next-Gen PV. Dr. Alejandra Guerchicoff will moderate a dynamic panel of experts with rich real-life experiences in implementation of AI driven PV Platforms and discuss its benefits and challenges.

Partial Speakers:

  • [Moderator] Dr. Alejandra Guerchicoff - Industry Leader – TCS ADD™ Safety, TCS
  • Michael Murphy, Executive Director, Head of Pharmacovigilance Operations, Amgen
  • Mariette Boerstoel Streefland, Senior Vice President Patient Safety, Chief Safety Officer, AstraZeneca
  • Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy & Technology, IDC
  • Dr. Aparna Patkar, Director, Life Sciences, TCS




AI Driven Safety Case Processing – Learnings and Experiences

5th Oct | 11:20AM ET – 11:40AM ET

The past decade has seen unprecedented technology revolution in PV. With a spurt in innovations, advanced scientific discoveries, personalized medicines and global portfolios, the pharma industry must rely on digital technologies to handle the innate complexities.

Technology providers responded by conceptualizing and developing disruptive AI-ML platforms, introduce them into the market and gradually replace the traditional point automation PV tools. In this dynamic and interactive presentation, Naru and Tejas will present next-gen solutions for PV and drive the audience into key technical discussions with real experiences of adopting and implementing AI driven PV platforms.


  • Narayanan R. (Naru), Chief Architect and Head of Clinical & Safety Platforms, TCS ADD™, Tata Consultancy Services